http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101404893-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
filingDate | 2010-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2014-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101404893-B1 |
titleOfInvention | Trans-4-[[(5s)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl] (2-methyl-2h-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1h-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid |
abstract | (Trifluoromethyl) phenyl] methyl] (2-methyl-2H-tetrazol-5-yl) Amino] -2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin- 1-yl] methyl] -cyclohexanecarboxylic acid, its free acid or a pharmaceutically acceptable salt , Hydrates and crystalline forms of hydrates, pharmaceutical formulations and methods of use thereof. |
priorityDate | 2009-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 224.